By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market Tuesday that it posted revenues of $867.1 million for the third quarter, an 8 percent increase over the third quarter of 2009.

On a non-GAAP basis, revenues increased to $868.7 million for the quarter, compared to $805.1 million in Q3 2009. Wall Street analysts had expected revenues of $856.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.